News & Views | Published:


Copy number signatures in ovarian cancer

Nature Geneticsvolume 50pages12081209 (2018) | Download Citation


A new study uncovers novel copy number signatures in ovarian cancer genomes. This work sheds light on mutational processes driving ovarian cancer, reveals the distribution of copy number features across the patient population and identifies new genomic properties related to treatment response.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Cancer Genome Atlas Research Network. Nature 474, 609–615 (2011).

  2. 2.

    McIntyre, G. et al. Nat. Genet. (2018).

  3. 3.

    Patch, A.-M. et al. Nature 521, 489–494 (2015).

  4. 4.

    McPherson, A. et al. Nat. Genet. 48, 758–767 (2016).

  5. 5.

    Wang, Y. K. et al. Nat. Genet. 49, 856–865 (2017).

  6. 6.

    Davies, H. et al. Nat. Med. 23, 517–525 (2017).

  7. 7.

    Alexandrov, L. B. et al. Nature 500, 415–421 (2013).

Download references

Author information


  1. Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    • Sohrab P. Shah


  1. Search for Sohrab P. Shah in:

Competing Interests

S.P.S. is a principal shareholder of Contextual Genomics, Inc.

Corresponding author

Correspondence to Sohrab P. Shah.

About this article

Publication history



Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing